Replay available

Arcutis Biotherapeutics, Inc. (ARQT) Q4 2025 Earnings Call

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.

Wed, February 25, 2026 at 4:30 PMendedReplay
Arcutis Biotherapeutics, Inc. (ARQT) Q4 2025 Earnings Call

Hosted by

Featured presenters

Brian Sholkoff

Head of Investor Relations

Frank Watanabe

President and CEO

Todd Edwards

Chief Commercial Officer

Patrick Burnett

Chief Medical Officer

Lata Vyravan

Chief Financial Officer

Seamus Fernandez

Analyst at Guggenheim

Tyler Van Buren

Analyst at TD Cowen

Judah Frommer

Analyst at Morgan Stanley

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arcutis Biotherapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.634 Ladies and gentlemen, thank you for standing by. 00:00:02.634 -- 00:00:08.140 Welcome to the Arcutus Biotherapeutics Inc's fourth quarter fiscal year 2025 00:00:08.140 -- 00:00:13.246 earnings conference call. At this time, all participants are in 00:00:13.246 -- 00:00:18.613 a listen-only mode. After the speaker's presentation, there will be a question and answer 00:00:18.613 -- 00:00:23.659 session. To ask a question during the session, you will need to press star 11 on 00:00:23.659 -- 00:00:29.005 your telephone. You will then hear an automated message advising your hand is raised. 00:00:29.005 -- 00:00:33.250 To withdraw your question, please press star 1-1 again. 00:00:33.250 -- 00:00:37.134 Please be advised that today's conference is being recorded. 00:00:37.134 -- 00:00:42.721 I would like now to turn the conference over to Brian Sholkoff, Head of Investor Relations. 00:00:42.721 -- 00:00:45.321 Please go ahead. 00:00:45.564 -- 00:00:49.989 Thank you, Michelle. Good afternoon, everyone, and thank you for joining us today to 00:00:49.989 -- 00:00:55.055 review our fourth quarter and full year 2025 financial results and business 00:00:55.055 -- 00:01:01.183 updates. Slides for today's call are available on the investor section of the RQDIS website. 00:01:01.183 -- 00:01:06.271 Joining me on the call today are Frank Watanabe, President and CEO of RQDIS, Todd 00:01:06.271 -- 00:01:11.398 Edwards, Chief Commercial Officer, Patrick Burnett, Chief Medical Officer, and 00:01:11.398 -- 00:01:16.466 Lata Vyravan, Chief Financial Officer. I'd like to remind everyone that we will be 00:01:16.466 -- 00:01:19.690 making forward-looking statements during this call. 00:01:19.690 -- 00:01:24.237 These statements are subject to certain risks...